Xalkori 200 MG capsule 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FG2RB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,196
Award facts
- Contract value 100% obligated
- $15,195.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,195.73 to AmerisourceBergen Drug Corp for Xalkori 200 mg capsules (60-count units) on December 26, 2025, with an ultimate completion date of January 20, 2026. This firm fixed price delivery order was competitively awarded without a set-aside designation and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. Xalkori is a specialized pharmaceutical product used in oncology treatment, reflecting the Defense Logistics Agency's role in supplying critical medications to military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.99 billion and extends through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a prime vendor for the Defense Logistics Agency's comprehensive pharmaceutical supply chain, providing brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs globally. The company's contract portfolio demonstrates its capability to manage both high-volume commodity medications and specialized therapeutic products across multiple disease categories, serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FG2RB?
SPE2DR26FG2RB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 26, 2025.
How much is contract SPE2DR26FG2RB worth?
The government has obligated $15,196 on SPE2DR26FG2RB.
Is contract SPE2DR26FG2RB an order under another contract?
Yes. SPE2DR26FG2RB is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG2RB competed?
The extent of competition for SPE2DR26FG2RB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award